Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.

Pathology, research and practice - 1 Jan 2001

Boltze C, Schneider-Stock R, Jäger V, Roessner A

Abstract excerpt

We investigated a lipoma and a well-differentiated/dedifferentiated liposarcoma (WD/DDL), occurring simultaneously in one patient for the possible role of p53 and mdm2 in the molecular oncogenesis of liposarcoma and tumor progression. The hypothesis tested was if there is a continuum in the development from lipoma to liposarcoma. Lipoma was characterized by a lack of p53 mutation, p53 LOH and p53 protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorescent Antibody Technique, Indirect
Share to Immunoenzyme Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Ki-67 Antigen

Share to Lipoma

Share to Liposarcoma

Share to Neoplasms, Multiple Primary

Share to Proto-Oncogene Proteins c-mdm2

Share to Soft Tissue Neoplasms

Source

Identifiers

PMID: 11518050
DOI: 10.1078/0344-0338-00128

Genes

MDM2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.PMID 11518050Read ↗

Distinct mdm2/p53 expression patterns in liposarcoma subgroups: implications for different pathogenetic mechanisms.Semantic proximity Read ↗

MDM2-p53 in liposarcoma: The need for targeted therapies with novel mechanisms of actionSemantic proximity Read ↗

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumoursSemantic proximity Read ↗

Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.Semantic proximity Read ↗

High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.Semantic proximity Read ↗

MDM2 gene amplification in bone and soft-tissue tumors: association with tumor progression in differentiated adipose-tissue tumors.Semantic proximity Read ↗

A rare case of well-differentiated liposarcoma with CDK4 amplification but without MDM2 amplificationSemantic proximity Read ↗

Clinical and Biological Significance of <i>CDK4</i> Amplification in Well-Differentiated and Dedifferentiated LiposarcomasSemantic proximity Read ↗

Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.Semantic proximity Read ↗

MDM2 Amplified Sarcomas: A Literature ReviewSemantic proximity Read ↗

Gene Expression Profiling of Liposarcoma Identifies Distinct Biological Types/Subtypes and Potential Therapeutic Targets in Well-Differentiated and Dedifferentiated LiposarcomaSemantic proximity Read ↗

The novel role of MDM2 in the diagnosis and treatment of dedifferentiated liposarcomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.